Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage

被引：3
作者：
Donate-Correa, Javier [1 ]
Muros-de-Fuentes, Mercedes [2 ]
Mora-Fernandez, Carmen [1 ]
Navarro-Gonzalez, Juan F. [1 ,3 ]
机构：
[1] Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Tenerife, Spain
[2] Hosp Univ Nuestra Senora Candelaria, Serv Anal Clin, Tenerife, Spain
[3] Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, Tenerife, Spain
来源：
MEDICINA CLINICA | 2013年 / 140卷 / 09期
关键词：
CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; KLOTHO GENE POLYMORPHISM; VITAMIN-D; ENDOTHELIAL DYSFUNCTION; MORTALITY RISK; PHOSPHATE; KIDNEY; FGF23; PHOSPHORUS;
D O I：
10.1016/j.medcli.2012.11.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：420 / 423
页数：4
相关论文
共 50 条
[41]   Soluble α-Klotho and Its Relation to Kidney Function and Fibroblast Growth Factor-23 [J].
Scholze, Alexandra ;
Liu, Ying ;
Pedersen, Lise ;
Xia, Shengqiang ;
Roth, Heinz J. ;
Hocher, Berthold ;
Rasmussen, Lars Melholt ;
Tepel, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :E855-E861
[42]   Fibroblast growth factor 23 and the heart [J].
Faul, Christian .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (04) :369-375
[43]   α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent [J].
Erben, Reinhold G. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (04) :229-235
[44]   Decreased Expression of Thrombomodulin in Endothelial Cells by Fibroblast Growth Factor-23/-Klotho [J].
Tanaka, Kenji ;
Salunya, Tancharoen ;
Motomiya, Yoshihiro ;
Motomiya, Yasuki ;
Oyama, Yoko ;
Yamakuchi, Munekazu ;
Maruyama, Ikuro .
THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (04) :395-404
[45]   Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk [J].
Berezin, Alexander E. ;
Berezin, Alexander A. .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) :2549-2556
[46]   Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease [J].
Yanucil, Christopher ;
Kentrup, Dominik ;
Campos, Isaac ;
Czaya, Brian ;
Heitman, Kylie ;
Westbrook, David ;
Osis, Gunars ;
Grabner, Alexander ;
Wende, Adam R. ;
Vallejo, Julian ;
Wacker, Michael J. ;
Navarro-Garcia, Jose Alberto ;
Ruiz-Hurtado, Gema ;
Zhang, Fuming ;
Song, Yuefan ;
Linhardt, Robert J. ;
White, Kenneth ;
Kapiloff, Michael S. ;
Faul, Christian .
KIDNEY INTERNATIONAL, 2022, 102 (02) :261-279
[47]   Fibroblast Growth Factor 23, Klotho, and Disordered Mineral Metabolism in Chronic Kidney Disease: Unraveling the Intricate Tapestry of Events and Implications for Therapy [J].
Gutierrez, Orlando M. .
JOURNAL OF RENAL NUTRITION, 2013, 23 (03) :250-254
[48]   A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway [J].
Wang, Joseph ;
Vogt, Beth ;
Sethi, Sidharth Kumar ;
Sampson, Matthew G. ;
Vega-Warner, Virginia ;
Otto, Edgar A. ;
Raina, Rupesh .
KIDNEY INTERNATIONAL REPORTS, 2017, 2 (06) :1238-1242
[49]   Fibroblast Growth Factor-23 and Cardiac Structure and Function [J].
Agarwal, Isha ;
Ide, Noriko ;
Ix, Joachim H. ;
Kestenbaum, Bryan ;
Lanske, Beate ;
Schiller, Nelson B. ;
Whooley, Mary A. ;
Mukamal, Kenneth J. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (01) :e000584
[50]   Direct and indirect effects of fibroblast growth factor 23 on the heart [J].
Nakano, Toshiaki ;
Kishimoto, Hiroshi ;
Tokumoto, Masanori .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345